Renaissance Technologies
KRSA

Renaissance Technologies’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Renaissance Technologies’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,516
Closed -$34.2K – 3526
2024
Q4 		$34.2K Buy
+1,516
New +$4.22K ﹤0.01% 3432
2023
Q2 		– Sell
-619
Closed -$38K – 3984
2023
Q1 		$38K Sell
619
-692
-53% -$8.73K ﹤0.01% 3713
2022
Q4 		$120K Sell
1,311
-713
-35% -$8.43K ﹤0.01% 3562
2022
Q3 		$244K Sell
2,024
-1,234
-38% -$21.2K ﹤0.01% 3296
2022
Q2 		$250K Buy
3,258
+1,097
+51% +$15.7K ﹤0.01% 3550
2022
Q1 		$336K Sell
2,161
-310
-13% -$7.47K ﹤0.01% 3417
2021
Q4 		$595K Buy
2,471
+1,955
+379% +$92.3K ﹤0.01% 2993
2021
Q3 		$222K Sell
516
-1,518
-75% -$99.3K ﹤0.01% 3170
2021
Q2 		$1.11M Buy
2,034
+368
+22% +$23K ﹤0.01% 2622
2021
Q1 		$651K Buy
1,666
+1,538
+1,202% +$116K ﹤0.01% 2804
2020
Q4 		$55K Buy
+128
New +$8.73K ﹤0.01% 3312
2020
Q3 		– Sell
-607
Closed -$502K – 3423
2020
Q2 		$502K Buy
607
+208
+52% +$17.4K ﹤0.01% 2874
2020
Q1 		$148K Buy
+399
New +$28.5K ﹤0.01% 3160

Other funds holding KRSA

TCP
Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Renaissance Technologies's KRSA Position: Q1 2025 in Review

Renaissance Technologies sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q1 2025, closing a stake of 1,516 shares — an estimated $34.2K sold.

Renaissance Technologies first reported a position in KRSA in Q1 2020 and held it in 13 quarters. The position peaked at $1.11M in Q2 2021. 17 funds tracked by Wall St. Rank hold KRSA as of Q1 2025.

  • Renaissance Technologies reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Renaissance Technologies sold 1,516 Korsana Biosciences, Inc. Common Stock shares in Q1 2025, an estimated $34.2K.
  • Renaissance Technologies first reported a position in Korsana Biosciences, Inc. Common Stock in Q1 2020 and held it in 13 quarters.
  • Renaissance Technologies's Korsana Biosciences, Inc. Common Stock position peaked at $1.11M in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q1 2025.

Based on Renaissance Technologies's 13F filing for Q1 2025, filed 14 May 2025.